Recombinant follicle-stimulating hormone versus human menopausal gonadotropin in the late follicular phase during ovarian hyperstimulation for in vitro fertilization

By Commenges-Ducos M.   Piault S.   Papaxanthos A.   Ribes C.   Dallay D.   Commenges D.  

Fertility and Sterility, Vol. 78, Iss. 5, 2002-11 ,pp. : 1049-1054

Elsevier

Access to resources Recommend Favorite

Follicle-stimulating hormone receptor gene mutations are rare in Japanese women with premature ovarian failure and polycystic ovary syndrome

By Takakura K.   Takebayashi K.   Wang H.-Q.   Kimura F.   Kasahara K.   Noda Y.  

Fertility and Sterility, Vol. 75, Iss. 1, 2001-01 ,pp. : 207-209

Elsevier

Access to resources Recommend Favorite

Human menopausal gonadotropin and recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles

By van Wely M.   Westergaard L.G.   Bossuyt P.M.M.   van der Veen F.  

Fertility and Sterility, Vol. 80, Iss. 5, 2003-11 ,pp. : 1121-1122

Elsevier

Access to resources Recommend Favorite

Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders 1

By Mitwally M.F.M.   Casper R.F.  

Fertility and Sterility, Vol. 77, Iss. 4, 2002-04 ,pp. : 776-780

Elsevier

Access to resources Recommend Favorite

Updated meta-analysis of recombinant follicle-stimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproduction

By Daya S.  

Fertility and Sterility, Vol. 77, Iss. 4, 2002-04 ,pp. : 711-714

Elsevier

Access to resources Recommend Favorite